Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01PUS
|
|||
| Drug Name |
PMID27215781-Compound-32
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
C4T S.C. A.R.L
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H23NO5S2
|
|||
| Canonical SMILES |
C1CCC2(CC1)N(C(=O)C3=C(O2)C=C(C=C3)OS(=O)(=O)C4=CC=CS4)CC5=CC=CC=C5
|
|||
| InChI |
1S/C24H23NO5S2/c26-23-20-12-11-19(30-32(27,28)22-10-7-15-31-22)16-21(20)29-24(13-5-2-6-14-24)25(23)17-18-8-3-1-4-9-18/h1,3-4,7-12,15-16H,2,5-6,13-14,17H2
|
|||
| InChIKey |
XBCSLRKNSRBEMJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | . | [1] |
| Target's Patent Info | Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.